I-Mab ADR (IMAB) Social Stream

I-Mab ADR (IMAB): $6.14

0.00 (0.00%)

POWR Rating

Component Grades

We have 9 different ratings for every stock to help you appreciate its future potential. You can unlock it all now.
Just click the link above.

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add IMAB to Watchlist
Sign Up

Industry: Medical - Pharmaceuticals

Ranked

of 171

in industry

See All 'A' Rated Buy Stocks

Featured Post From StockTwits About IMAB

$IMAB NEW ARTICLE : I-Mab Reports Positive Interim Analysis from Phase 2/3 Study of its GM-CSF Antibody Plonmarlimab (TJM2) to Treat Patients with Severe COVID-19 https://www.stck.pro/news/IMAB/14862068

STCKPRO, published August 11, 2021

Most Popular Stories View All

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

I-Mab ADR (IMAB) Social Stream

I-Mab ADR (IMAB): $6.14

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Industry: Medical - Pharmaceuticals

Ranked

of 171

Featured Post From StockTwits About IMAB

Most Popular Stories View All

• Investor Alert: Why the Bear Market Might End on 2/1?

• 3 Stocks You Shouldn't Hesitate to Buy

• 4 Stocks You'll Want to Sell Now

• Owning These 3 Stocks Could Make You Rich in 10 Years

• 6 Reasons to Become Bullish Now

Get Free Updates

I-Mab ADR (IMAB) Social Stream

I-Mab ADR (IMAB): $6.14

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Industry: Medical - Pharmaceuticals

Ranked

of 171

Featured Post From StockTwits About IMAB

GET POWR RATINGS... FREE!

Most Popular Stories View All

• Investor Alert: Why the Bear Market Might End on 2/1?

• 3 Stocks You Shouldn't Hesitate to Buy

• 4 Stocks You'll Want to Sell Now

• Owning These 3 Stocks Could Make You Rich in 10 Years

• 6 Reasons to Become Bullish Now

Get Free Updates

Get Free Updates